wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30243969-EB92498B-48B2-41DF-A851-8F48119AC2F2
Q30243969-EB92498B-48B2-41DF-A851-8F48119AC2F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30243969-EB92498B-48B2-41DF-A851-8F48119AC2F2
Attributable Risk of Infection to mTOR Inhibitors Everolimus and Temsirolimus in the Treatment of Cancer.
P2860
Q30243969-EB92498B-48B2-41DF-A851-8F48119AC2F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30243969-EB92498B-48B2-41DF-A851-8F48119AC2F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3450210dd0b7ec80e3c008e5999349e1e3c2a9fe
P2860
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.